Fortitude Family Office LLC Invests $117,000 in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Fortitude Family Office LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, HoldingsChannel reports. The firm acquired 1,300 shares of the exchange traded fund’s stock, valued at approximately $117,000.

Other institutional investors have also recently added to or reduced their stakes in the company. FMR LLC raised its position in shares of SPDR S&P Biotech ETF by 13.6% in the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after buying an additional 830 shares during the period. Beaton Management Co. Inc. acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $212,000. Prairie Wealth Advisors Inc. raised its holdings in SPDR S&P Biotech ETF by 3.6% in the second quarter. Prairie Wealth Advisors Inc. now owns 6,616 shares of the exchange traded fund’s stock valued at $613,000 after buying an additional 231 shares during the period. Robinson Value Management Ltd. lifted its position in SPDR S&P Biotech ETF by 1.2% during the third quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock valued at $1,329,000 after buying an additional 155 shares in the last quarter. Finally, Envestnet Asset Management Inc. grew its stake in SPDR S&P Biotech ETF by 12.5% during the second quarter. Envestnet Asset Management Inc. now owns 186,400 shares of the exchange traded fund’s stock worth $17,281,000 after buying an additional 20,685 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.6 %

SPDR S&P Biotech ETF stock opened at $92.31 on Friday. The firm has a market capitalization of $7.04 billion, a P/E ratio of 11.47 and a beta of 1.11. The firm has a fifty day moving average of $95.67 and a 200-day moving average of $97.09. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.